Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation.
Ali N, Sharma AA, de Rezende ACP, Otegbeye F, Latif BM, Kerbauy MN, Cooper BW, Sanchez G, Metheny L, Bal SK, Sakuraba R, Tomlinson BK, Boughan KM, Kerbauy L, Malek E, Ribeiro AF, Gallogly M, Mansur D, Pereira G, Weltman E, Sekaly RP, de Lima M, Caimi PF, Hamerschlak N. Ali N, et al. Among authors: otegbeye f. Transplant Cell Ther. 2022 Jul;28(7):370.e1-370.e10. doi: 10.1016/j.jtct.2022.04.001. Epub 2022 Apr 11. Transplant Cell Ther. 2022. PMID: 35421620 Free article. Clinical Trial.
Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation.
Tandra A, Covut F, Cooper B, Creger R, Brister L, McQuigg B, Caimi P, Malek E, Tomlinson B, Lazarus HM, Otegbeye F, Kolk M, de Lima M, Metheny L. Tandra A, et al. Among authors: otegbeye f. Leuk Lymphoma. 2018 Jul;59(7):1644-1651. doi: 10.1080/10428194.2017.1390234. Epub 2017 Dec 4. Leuk Lymphoma. 2018. PMID: 29199482
Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia.
Covut F, Gupta D, Pinto R, Dambrosio N, El Jurdi N, Meyerson H, Ueda M, Kolk M, Creger R, Metheny L, Cooper BW, Caimi PF, Malek E, Otegbeye F, Lazarus HM, De Lima M, Tomlinson BK. Covut F, et al. Among authors: otegbeye f. Clin Lymphoma Myeloma Leuk. 2019 Feb;19(2):73-82. doi: 10.1016/j.clml.2018.11.001. Epub 2018 Nov 12. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30528848
Low-Dose Azacitidine with DNMT1 Level Monitoring to Treat Post-Transplantation Acute Myelogenous Leukemia or Myelodysplastic Syndrome Relapse.
Ueda M, El-Jurdi N, Cooper B, Caimi P, Baer L, Kolk M, Brister L, Wald DN, Otegbeye F, Lazarus HM, Sandmaier BM, William B, Saunthararajah Y, Woost P, Jacobberger JW, de Lima M. Ueda M, et al. Among authors: otegbeye f. Biol Blood Marrow Transplant. 2019 Jun;25(6):1122-1127. doi: 10.1016/j.bbmt.2018.12.764. Epub 2018 Dec 30. Biol Blood Marrow Transplant. 2019. PMID: 30599207 Free article.
Gastrointestinal Microbiome and Mycobiome Changes during Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study.
El Jurdi N, Filali-Mouhim A, Salem I, Retuerto M, Dambrosio NM, Baer L, Lazarus HM, Caimi P, Cooper B, Tomlinson B, Metheny L, Malek E, Otegbeye F, Sekaly RP, Ghannoum M, de Lima M. El Jurdi N, et al. Among authors: otegbeye f. Biol Blood Marrow Transplant. 2019 Aug;25(8):1511-1519. doi: 10.1016/j.bbmt.2019.04.007. Epub 2019 Apr 5. Biol Blood Marrow Transplant. 2019. PMID: 30959164 Free article. Clinical Trial.
Treatment-related mortality following autologous hematopoietic stem cell transplantation is unaffected by timing of G-CSF administration.
Ali N, Cooper B, Tomlinson B, Metheny L, Caimi P, Boughan K, Gallogly M, Otegbeye F, Malek E, Lazarus H, Creger R, de Lima M. Ali N, et al. Among authors: otegbeye f. Bone Marrow Transplant. 2020 Aug;55(8):1697-1700. doi: 10.1038/s41409-020-0812-x. Epub 2020 Feb 5. Bone Marrow Transplant. 2020. PMID: 32024994 No abstract available.
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction models.
Dharmavaram G, Cao S, Sundaram S, Ayyappan S, Boughan K, Gallogly M, Malek E, Metheny L, Tomlinson B, Otegbeye F, Lazarus HM, Cooper B, Fu P, de Lima M, Caimi PF. Dharmavaram G, et al. Among authors: otegbeye f. Am J Hematol. 2020 Aug;95(8):918-926. doi: 10.1002/ajh.25837. Epub 2020 May 8. Am J Hematol. 2020. PMID: 32311162 Free article.
Inhibition of 15-PGDH Protects Mice from Immune-Mediated Bone Marrow Failure.
Smith JNP, Otegbeye F, Jogasuria AP, Christo KF, Antczak MI, Ready JM, Gerson SL, Markowitz SD, Desai AB. Smith JNP, et al. Among authors: otegbeye f. Biol Blood Marrow Transplant. 2020 Aug;26(8):1552-1556. doi: 10.1016/j.bbmt.2020.04.010. Epub 2020 May 15. Biol Blood Marrow Transplant. 2020. PMID: 32422251 Free PMC article.
35 results